Newsfeeds Archive - Page 5 of 7

1 minute read

Rare Disease Player BridgeBio Pharma Draws Attention Of Big Pharma Companies, Gets Takeover Interest

March 27, 7:50 AM

BridgeBio Pharma Inc (NASDAQ: BBIO) is reportedly attracting takeover interest as some large pharmaceutical companies are studying a potential acquisition of the biotech firm.

BBIO

2 minute read

First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday’s Pre-Market Session

By Lisa Levin

March 27, 6:37 AM

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

BBIO

1 minute read

Health Care ETFs Have Lost In The Last Month – These Top Pharma Stocks Are The Reason

By Vandana Singh

March 7, 8:34 PM

The Health Care Select Sector SPDR Fund (NYSE:XLV), heavily tilted towards mega-caps, lost around 5.25% over the last month, with substantial companies…

ABBV

1 minute read

Raymond James Maintains Outperform on BridgeBio Pharma, Raises Price Target to $29

By Benzinga Newsdesk

March 7, 5:54 AM

Raymond James analyst Dane Leone maintains BridgeBio Pharma (NASDAQ:BBIO) with a Outperform and raises the price target from $17 to $29.

BBIO

2 minute read

Markets
News

Tesla, Amazon, Ambrx, BridgeBio, Azul: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

March 6, 8:52 PM

U.S. markets closed mixed on Monday as investors and traders turned their attention toward Federal Reserve Chair Jerome…

AMAM

1 minute read

Why BioMarin Shares Are Plunging Today?

By Vandana Singh

March 6, 4:10 PM

Biomarin Pharmaceutical Inc (NASDAQ: BMRN) shares are falling in reaction to positive data from BridgeBio Pharma Inc's (NASDAQ: BBIO) dwarfism drug, heating the competition.

BBIO

3 minute read

Nasdaq Rises 50 Points; Ciena Earnings Top Expectations

By Lisa Levin

March 6, 3:24 PM

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Monday. The Dow traded up 0.16% to 33,444.91 while the NASDAQ rose 0.43% to 11,739.11. The S&P 500 also rose, gaining, 0.35% to 4,059.80.

ACRS

3 minute read

Dow Jumps Over 100 Points; BridgeBio Pharma Shares Spike Higher

By Lisa Levin

March 6, 1:25 PM

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. The Dow traded up 0.42% to 33,531.77 while the NASDAQ rose 0.97% to 11,802.73. The S&P 500 also rose, gaining, 0.69% to 4,073.40.

ACRS

2 minute read

BridgeBio’s Dwarfism Candidate Shows Favorable Height Increase, Safety Profile

By Vandana Singh

March 6, 11:55 AM

BridgeBio Pharma Inc (NASDAQ: BBIO) announced results from PROPEL2 Phase 2 trial of infigratinib in children with achondroplasia, a genetic condition affecting a protein in the body called the fibroblast growth factor receptor.

BBIO

1 minute read

What’s Going On With Kala Pharmaceuticals Shares Today

By Aaron Bry

March 6, 11:33 AM

Kala Pharmaceutical (NASDAQ: KALA) shares skyrocketed more than 20% Monday morning on higher-than-average volume. On an average market day, Kala shares trade about 2.5 million times throughout the day.

ALBT